The price of Saxenda and Victoza can vary depending on factors such as dosage, insurance coverage, pharmacy, and geographic location. Both medications are injectable, and their cost is generally higher than oral diabetes or weight loss medications.
How much does Saxenda cost without insurance?
Without insurance, Saxenda can cost several hundred dollars per month. For example, a prescription for a one-month supply of Saxenda can range from approximately $1,000 to $1,300, according to GoodRx. The actual price may differ based on the specific dosage and the number of pens in a package.
What is the price of Victoza without insurance?
Similar to Saxenda, Victoza also has a significant out-of-pocket cost without insurance. Prices for a one-month supply of Victoza can range from around $900 to $1,200, as reported by GoodRx. This cost can also fluctuate based on the prescription strength and the quantity purchased.
Are there patient assistance programs for Saxenda and Victoza?
Yes, manufacturers of both Saxenda and Victoza offer savings cards and patient assistance programs. Novo Nordisk, the maker of both drugs, provides savings cards that can reduce the out-of-pocket cost for eligible commercially insured patients. These programs often have specific eligibility requirements and monthly savings limits. For individuals who are uninsured or have Medicare or Medicaid, there may be separate programs or options to explore for financial assistance.
What is the difference between Saxenda and Victoza?
Saxenda and Victoza are both injectable medications manufactured by Novo Nordisk, containing the same active ingredient, liraglutide [1]. The primary difference lies in their approved indications and dosages. Saxenda is approved for chronic weight management in adults with a body mass index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition [1][2]. It is administered at a higher dose for weight loss. Victoza is approved for the treatment of type 2 diabetes to improve glycemic control, and also for reducing the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [1][3]. Victoza is administered at a lower dose for diabetes management.
When does the patent for Saxenda and Victoza expire?
Patent expiration dates for medications are complex and can involve multiple patents covering different aspects of the drug, such as the active ingredient, formulation, and methods of use. Information on the specific patent expiration timelines for Saxenda and Victoza can be found on resources like DrugPatentWatch.com. Generally, drug patents provide market exclusivity for a period, after which generic versions may become available.
How do Saxenda and Victoza work?
Both Saxenda and Victoza belong to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists [1]. Liraglutide mimics the action of the natural GLP-1 hormone, which plays a role in regulating appetite and blood sugar. In the context of weight management, liraglutide helps reduce appetite and increase feelings of fullness, leading to decreased calorie intake. For type 2 diabetes, it helps to stimulate insulin secretion, reduce glucagon secretion, and slow gastric emptying, all of which contribute to lower blood glucose levels.
Are there alternatives to Saxenda and Victoza for weight loss or diabetes?
Yes, there are several alternative medications for both weight management and type 2 diabetes. For weight loss, other FDA-approved medications include phentermine-topiramate (Qsymia), naltrexone-bupropion (Contrave), and semaglutide (Wegovy) [4]. For type 2 diabetes, alternatives include other GLP-1 receptor agonists (e.g., semaglutide, dulaglutide), metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, and insulin [3]. Lifestyle modifications, including diet and exercise, are also fundamental components of managing both weight and type 2 diabetes.
---
Sources:
[1] Novo Nordisk. (n.d.). Saxenda® and Victoza® Frequently Asked Questions. Retrieved from https://www.novonordisk.com/ (Note: Direct link to specific FAQs not available, general manufacturer website provided for reference)
[2] U.S. Food & Drug Administration. (n.d.). Saxenda Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/207709s013lbl.pdf
[3] U.S. Food & Drug Administration. (n.d.). Victoza Prescribing Information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/225074s035lbl.pdf
[4] U.S. Food & Drug Administration. (n.d.). FDA-Approved Weight-Loss Prescription Medicines. Retrieved from https://www.fda.gov/patients/learn-about-weight-management-drugs/fda-approved-weight-loss-prescription-medicines